passage bio stock forecast

Tuesday, May 24, 2022 Edit

On average Wall Street analysts predict. The main clinical program involves PBGM01 which is being used to treat GM1 gangliosidosis and a phase 12.

Pasg Stock Price And Chart Nasdaq Pasg Tradingview

Passage Bio intends to raise 125 million in an upcoming IPO.

. Passage Bio has a fifty-two week low of 281 and a fifty-two week high of 2212. The average price target is 2060 with a high forecast of 3400 and a low forecast. Dec 30 2021 403AM EST.

Find a Dedicated Financial Advisor Now. NASDAQPASG Get Rating Wedbush upped their. Please note that any opinions estimates or.

According to analysts Passage Bios stock has a predicted upside of 29801 based on their 12-month price targets. Find the latest Passage Bio Inc. Furthermore Passage Bio Inc.

Is followed by the analysts listed above. PASG is covered since 2020. Passage Bio NASDAQ.

The companys stock has been forecasted to trade at an average price of 1814 over the course of. Some analysts who are covering this stock. In total the offering brought in 216 million for the.

6 equities research analysts have issued 12-month price objectives for Passage Bios stock. Ad Ensure Your Investments Align with Your Goals. The firm is developing genetic.

See Passage Bio Inc. The average PASSAGE BIO stock price prediction forecasts a potential upside of. Based on 6 Wall Street analysts offering 12 month price targets for Passage Bio in the last 3 months.

NASDAQPASG to Post Q2 2022 Earnings of 075 Per Share Wedbush Forecasts. On average they expect Passage Bios. The current number of active analytics during the last two years is 1.

What analysts cover Passage Bio. Our Stock Screener Makes it Effortless to Scan for Stocks With Updates in Real-time. PASG stock analyst estimates including earnings and revenue EPS upgrades and downgrades.

Bruce Goldsmith Courtesy Passage Bio Passages stock jumped 20 on Friday its first day trading from 18 to nearly 22. PASG stock quote history news and other vital information to help you with your stock trading and investing. Ad Dont miss out on opportunities open an account in 10 minutes.

Estimated cash runway extended into Q2 2024. Jan 8 2022 857PM EST. Their forecasts range from 600 to 3400.

Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of. Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business. PASGs average true range ATR is 022.

Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of. That PASSAGE BIOs share price could reach 1833 by Mar 8 2023. Ad Trade your view on equity volatility with VIX options and futures.

Searching for Financial Security. Passage Bio Inc PASG shares closed today at 10 above its 52 week low of 630 giving the company a market cap of 346M. Our Financial Advisors Offer a Wealth of Knowledge.

PASG - Passage Bio Inc. Ad Dont miss out on opportunities open an account in 10 minutes. 913a Nikola stock rises after narrower-than-expected loss revenue of.

PHILADELPHIA March 15 2022 GLOBE NEWSWIRE -- Passage Bio Inc. Ad Get the Inside Access Traders Are Using to Profit More and Win Bigger. PASG has filed to raise 125 million in an IPO of its common stock according to an S-1 registration statement.

What are analysts forecasts for Passage Bio stock. Summary of all time highs changes and price drops for Passage Bio. Passage Bio NASDAQPASG Get Rating last posted its quarterly earnings data on.

Passage Bio Inc. The 13 analysts offering price forecasts for Passage Bio have a median target of 2462 with a high estimate of 4500 and a low estimate. Analyst estimates including PASG earnings per share estimates and analyst recommendations.

PASG a clinical-stage genetic medicines. If you are looking for stocks with good return Passage Bio Inc. Passage Bio Inc PASG shares closed today at 05 above its 52 week low of 559 giving the company a market cap of 304M.

Bluebird Bio Biomarin Tabbed As Top Acquisition Targets